CATALYST THERAPEUTICS PTY LTD has a total of 20 patent applications. Its first patent ever was published in 2015. It filed its patents most often in Australia, Canada and China. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ASD THERAPEUTICS PARTNERS LLC, DUBOIS LAURENT and QUATTROPANI ANNA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | United States | 3 | |
#6 | WIPO (World Intellectual Property Organization) | 3 | |
#7 | Brazil | 1 | |
#8 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Garnier Jean-Marc | 17 |
#2 | Cuzzupe Anthony Nicholas | 13 |
#3 | Czabotar Peter Edward | 13 |
#4 | Lessene Guillaume Laurent | 13 |
#5 | Feutrill John Thomas | 13 |
#6 | Sharma Pooja | 13 |
#7 | Hildebrand Joanne Maree | 7 |
#8 | Wilks Andrew Frederick | 7 |
#9 | Lucet Isabelle | 7 |
#10 | Murphy James Michael | 7 |
Publication | Filing date | Title |
---|---|---|
WO2017020086A1 | Benzodiazepines as bromodomain inhibitors | |
EP3256452A1 | Inhibitors of necroptosis | |
EP3142667A1 | Methods for inhibiting necroptosis |